风险管理对宫颈癌术后患者化疗配合度及生活质量的影响研究
|
摘要
目的探究护理风险管理对宫颈癌化疗患者的影响。方法选取我院收治的宫颈癌术后同步化疗患者作为研究对象,根据入院时间分为对照组和观察组。比较两组患者在护理过程中的风险事件发生情况以及患者对于护理的满意度。结果风险管理干预后,患者的生活质量、满意度和配合度得分明显增加,风险事件发生率明显降低,护理满意率提高(p<0.05)。结论对宫颈癌化疗患者采用护理风险管理干预,生活质量明显提高,减少发生风险事件。
Objective To explore the effect of nursing risk management on patients with cervical cancer chemotherapy. Method Patients after cervical cancer surgery who underwent concurrent chemotherapy in our hospital were selected as study subjects. According to the time of admission, they were divided into control group and observation group. The incidence of risk events during the nursing process and patients' satisfaction with care were compared between the two groups. Results After risk management intervention, the scores of quality of life, satisfaction and compliance and the rate satisfaction with nursing were significantly higher, and the incidence of risk events significantly declined(p<0.05). Conclusion The application of nursing risk management among patients with chemotherapy for cervical cancer significantly increases the quality of life and reduces risk events.
Objective To explore the effect of nursing risk management on patients with cervical cancer chemotherapy. Method Patients after cervical cancer surgery who underwent concurrent chemotherapy in our hospital were selected as study subjects. According to the time of admission, they were divided into control group and observation group. The incidence of risk events during the nursing process and patients' satisfaction with care were compared between the two groups. Results After risk management intervention, the scores of quality of life, satisfaction and compliance and the rate satisfaction with nursing were significantly higher, and the incidence of risk events significantly declined(p<0.05). Conclusion The application of nursing risk management among patients with chemotherapy for cervical cancer significantly increases the quality of life and reduces risk events.
引文
1 谢诺.护理风险管理在宫颈癌患者术后化疗中的效果观察[J].贵阳中医学院学报,2014,36(3):127-129
2 Yin ZM,Yu AJ,Wu MJ,et al.Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neuroendocrine cervical carcinoma[J].European journal of gynaecological oncology,2015,36(3):326-329
3 王庆碧.护理风险管理及临床应用效果分析[J].医院管理论坛,2014,31(5):38-40
4 许璐,陈梅忠,覃丽珍,等.风险管理在淋巴瘤化疗病区护理管理中的应用[J].广西医科大学学报,2016,33(6):1084-1086
5 李娟,叶海瑛.风险管理对白血病患者PICC护理效果的影响[J].实用临床医药杂志,2015,19(22):108-109
6 Mallmann P,Mallmann C.Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer[J].Oncol Res Treat,2016,39(9):522-524
7 Zhang Y,Yang Z,Zhou Y,et al.Efficacy of concurrent singleagent chemotherapy using radiotherapy in patients with cervical cancer:a meta-analysis[J].Int J Clin Exp Med,2015,8(6):8661-8673
8 刘淑英,梁冠冕.肿瘤化疗药物静脉输液风险管理的研究进展[J].中华现代护理杂志,2014,20(28):3662-3664
9 刘弘扬,奈嫚嫚,封全灵.局部晚期宫颈癌术前新辅助化疗效果分析[J].广东医学,2014,35(4):556-558
10 葛利越.护理风险管理在预防恶性肿瘤化疗不良事件发生中的应用[J].中华现代护理杂志,2014,20(5):574-577
11 张梅梅,丁宇,文君,等.护理风险管理在乳腺癌新辅助化疗患者中的应用[J].齐鲁护理杂志,2015(22):110-111
12 Zhi Huang,Shuai Zhang,Yaping Shen,et al.Influence of MDR1methylation on the curative effect of interventional embolism chemotherapy for cervical cancer[J].Ther Clin Risk Manag,2016,12:217-223
13 Hongwu Wen,Tongyu Liu,Zhaoyi Feng,et al.Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer[J].Journal of Cancer Therapy,2015,6:1075-1082
14 张秀霞.风险管理对提高急诊护理干预质量及降低护理风险的影响[J].医院管理论坛,2014,31(12):45-47
15 Yan WM,Li XZ,Yu ZL,et al.Clinical value of concurrent radiochemotherapy in cervical cancer and comparison of ultrasonography findings before and after radiochemotherapy[J].Genet Mol Res,2015,14(2):3633-3639
2 Yin ZM,Yu AJ,Wu MJ,et al.Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neuroendocrine cervical carcinoma[J].European journal of gynaecological oncology,2015,36(3):326-329
3 王庆碧.护理风险管理及临床应用效果分析[J].医院管理论坛,2014,31(5):38-40
4 许璐,陈梅忠,覃丽珍,等.风险管理在淋巴瘤化疗病区护理管理中的应用[J].广西医科大学学报,2016,33(6):1084-1086
5 李娟,叶海瑛.风险管理对白血病患者PICC护理效果的影响[J].实用临床医药杂志,2015,19(22):108-109
6 Mallmann P,Mallmann C.Neoadjuvant and Adjuvant Chemotherapy of Cervical Cancer[J].Oncol Res Treat,2016,39(9):522-524
7 Zhang Y,Yang Z,Zhou Y,et al.Efficacy of concurrent singleagent chemotherapy using radiotherapy in patients with cervical cancer:a meta-analysis[J].Int J Clin Exp Med,2015,8(6):8661-8673
8 刘淑英,梁冠冕.肿瘤化疗药物静脉输液风险管理的研究进展[J].中华现代护理杂志,2014,20(28):3662-3664
9 刘弘扬,奈嫚嫚,封全灵.局部晚期宫颈癌术前新辅助化疗效果分析[J].广东医学,2014,35(4):556-558
10 葛利越.护理风险管理在预防恶性肿瘤化疗不良事件发生中的应用[J].中华现代护理杂志,2014,20(5):574-577
11 张梅梅,丁宇,文君,等.护理风险管理在乳腺癌新辅助化疗患者中的应用[J].齐鲁护理杂志,2015(22):110-111
12 Zhi Huang,Shuai Zhang,Yaping Shen,et al.Influence of MDR1methylation on the curative effect of interventional embolism chemotherapy for cervical cancer[J].Ther Clin Risk Manag,2016,12:217-223
13 Hongwu Wen,Tongyu Liu,Zhaoyi Feng,et al.Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer[J].Journal of Cancer Therapy,2015,6:1075-1082
14 张秀霞.风险管理对提高急诊护理干预质量及降低护理风险的影响[J].医院管理论坛,2014,31(12):45-47
15 Yan WM,Li XZ,Yu ZL,et al.Clinical value of concurrent radiochemotherapy in cervical cancer and comparison of ultrasonography findings before and after radiochemotherapy[J].Genet Mol Res,2015,14(2):3633-3639